Portfolio Company · Operating Co.

Agomab Therapeutics

Sector not classified · Website

Agomab Therapeuticsbacked byCanaan Partners

Current

Company Snapshot

Agomab Therapeutics is a portfolio company held by Canaan Partners. Profile compiled from public sources; submit updates to extend the public record.

Sector—

Parent PE firmCanaan Partners

Ownership statusCurrent

WebsiteVisit ↗

Ownership Context

Agomab Therapeutics is a current portfolio company of Canaan Partners. Public coverage of this company is grouped under its parent firm's profile.

Sources

https://canaan.com/companies

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Agomab Therapeutics and does not provide investment advice.

Other portfolio companies of Canaan Partners

Abyrx

Aceiss

Acesion Pharma ApS

Actio Biosciences, Inc.

ACTIVE Network

ActualyzeAI, Inc.

Advanced BioHealing

Aer Therapeutics, Inc.

See the full Canaan Partners portfolio.